Browsing: Encouraging

Izalontamab brengitecan (iza-bren; BL-B01D1), a first-in-class EGFR/HER3 bispecific antibody-drug conjugate (ADC), demonstrated encouraging antitumor activity in patients with previously treated…

Oral duvelisib (Copiktra) combined with oral azacitidine (Onureg) had a manageable safety profile and encouraging activity in patients with relapsed/refractory…

The addition of englumafusp alfa to glofitamab (Columvi) displayed encouraging efficacy and a safety profile consistent with glofitamab monotherapy in…

Combining ivonescimab (Akeso) with liposomal irinotecan (Onivyde) produced encouraging activity among patients with small cell lung cancer (SCLC) who previously…

Encouraging activity and tolerability were observed among patients with KRAS G12D–mutated non-small cell lung cancer (NSCLC) who received treatment with…

Combining ruxolitinib (Jakafi) with abemaciclib (Verzenio) demonstrated encouraging activity in a small cohort of patients with previously treated advanced myelofibrosis,…

At the 2026 Tandem Meetings, Shambavi Richard, MD, shared data from the phase 1b/2 DURGA-1 trial (NCT05850234) showing early and…